Aptevo Therapeutics Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Aptevo Therapeutics Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 9,071,082% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 5.8 times its market value (net cash). Higher than almost all Healthcare companies in United States.
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -21%In 3 years sales changed by -100% while total assets changed by -21%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-29.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 63% of Healthcare companies in United States.
Cash Cushion Ratio
5.8× cashCash, after subtracting all debt, is 5.8 times its market value (net cash).
Higher than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Aptevo Therapeutics Inc. owes $0.58 for every $1 it owns. Aptevo Therapeutics Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
0.0Investors pay $0.0 for every $1 of Aptevo Therapeutics Inc.'s yearly profit, lower than 98% of Healthcare companies in United States.
P/B ratio
0.48The share price is 0.48 times Aptevo Therapeutics Inc.'s book value per share, lower than 92% of Healthcare companies in United States.
Market cap
$3 MThe total market value of all of Aptevo Therapeutics Inc.'s shares at today's price (share price × number of shares), smaller than 96% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$6 MWhat Aptevo Therapeutics Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.34Net worth divided by the number of shares. The share price of $1.61 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-420.3%Aptevo Therapeutics Inc. lost 420.3% of its shareholders' money over the last year, lower than 92% of Healthcare companies in United States.
Owes vs Owns
0.58×Aptevo Therapeutics Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Dividend yield
NoneAptevo Therapeutics Inc. does not currently pay a dividend.
Profit growth
LossAptevo Therapeutics Inc. made a loss in each of the last two years.
Cash vs debt
Net cashAptevo Therapeutics Inc. held $17 M more cash than debt (net cash) at Dec 2025.
Questions
What is Aptevo Therapeutics Inc.'s P/E ratio?
Investors pay $0.0 for every $1 of Aptevo Therapeutics Inc.'s yearly profit, lower than 98% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Aptevo Therapeutics Inc.: $3 M ÷ $6 M (30 Jun 2026) = 0.5.
What is Aptevo Therapeutics Inc.'s return on equity?
Aptevo Therapeutics Inc. lost 420.3% of its shareholders' money over the last year, lower than 92% of Healthcare companies in United States.
How much does Aptevo Therapeutics Inc. owe compared with what it owns?
Aptevo Therapeutics Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Does Aptevo Therapeutics Inc. pay a dividend?
No. Aptevo Therapeutics Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.